Improving Outcomes in Patients With Refractory Idiopathic and Neurogenic Detrusor Overactivity: Management Strategies

Archives of Physical Medicine and Rehabilitation
David GinsbergThomas K Watanabe

Abstract

Neurogenic detrusor overactivity (NDO) is a lower urinary tract dysfunction commonly seen in rehabilitation settings. The emotional, medical, and financial consequences of NDO can be substantial and management typically requires a multidisciplinary team approach. Physiatrists need to be able to identify patients who require referral to specialists for diagnostic testing or higher-tiered treatment and need to engender open lines of communication between their patients and all treating clinicians. This requires an understanding of the evaluation, diagnosis, and treatment of neurogenic lower urinary tract dysfunctions.

References

Feb 24, 1998·Stroke; a Journal of Cerebral Circulation·K R BrittainC M Castleden
Jun 24, 1999·The Journal of Urology·B H ZornW D Steers
Jan 4, 2001·Stroke; a Journal of Cerebral Circulation·M PatelC D Wolfe
Aug 31, 2001·Journal of the American Geriatrics Society·N H Fultz, A R Herzog
Feb 22, 2002·Neurourology and Urodynamics·Paul AbramsUNKNOWN Standardisation Sub-committee of the International Continence Society
May 15, 2002·Urology·Osamu Yamaguchi
Dec 21, 2002·Urology·Alan J Wein, Eric S Rovner
Jun 18, 2003·Urology·Teh-Wei HuTimothy L Hunt
Jun 18, 2003·World Journal of Urology·W F StewartA J Wein
Jun 28, 2003·The Journal of Spinal Cord Medicine·Margie O'LearyMichael B Chancellor
Jan 10, 2004·The Journal of Urology·Nelson BennettMichael B Chancellor
Mar 17, 2004·Clinical Obstetrics and Gynecology·Diane Borello-France, Kathryn L Burgio
Jan 10, 2006·Journal of the American Geriatrics Society·Gary G KayJoseph G Ouslander
May 23, 2006·American Journal of Physical Medicine & Rehabilitation·Michael B ChancellorTimothy B Boone
Jun 5, 2007·Physical Medicine and Rehabilitation Clinics of North America·Gregory Samson, Diana D Cardenas
Jun 6, 2007·Cleveland Clinic Journal of Medicine·Matt T RosenbergShari A Page
Jun 3, 2008·Annales de réadaptation et de médecine physique : revue scientifique de la Société française de rééducation fonctionnelle de réadaptation et de médecine physique·M de SèzeG Amarenco
Feb 21, 2009·International Journal of Urology : Official Journal of the Japanese Urological Association·Osamu YamaguchiUNKNOWN Neurogenic Bladder Society
Mar 4, 2009·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Pradeep TyagiMichael B Chancellor
Jul 11, 2009·International Psychogeriatrics·Melanie LuppaSteffi G Riedel-Heller
Jun 10, 2010·International Journal of Clinical Practice·A WaggU Molander
Oct 1, 2010·Neurourology and Urodynamics·Aubrey ManackJudith K Jones
Oct 20, 2010·The Urologic Clinics of North America·E Ann Gormley
Apr 14, 2011·Neurourology and Urodynamics·Wassim ChaabaneXavier Game
Nov 11, 2011·CNS Neuroscience & Therapeutics·Michael Chancellor, Timothy Boone
Jan 13, 2012·The Journal of Urology·Alan J Wein
Jul 4, 2012·International Urogynecology Journal·Alana M MurphyHoward B Goldman
Oct 20, 2012·The Journal of Urology·Victor W NittiSender Herschorn
Oct 27, 2012·The Journal of Urology·E Ann GormleyUNKNOWN Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.